230 related articles for article (PubMed ID: 15273267)
41. Tattooing in prison: a risk factor for HCV infection among inmates in the Quebec's provincial correctional system.
Poulin C; Courtemanche Y; Serhir B; Alary M
Ann Epidemiol; 2018 Apr; 28(4):231-235. PubMed ID: 29576049
[TBL] [Abstract][Full Text] [Related]
42. [Prevalence infections and risk factors due to HIV, Hepatitis B and C in a prison establishment in Leiria].
Passadouro R
Acta Med Port; 2004; 17(5):381-4. PubMed ID: 16197845
[TBL] [Abstract][Full Text] [Related]
43. Prevalence of and risk factors for HCV among incarcerated people at Great Tehran Prison: a cross-sectional study.
SeyedAlinaghi S; Farhoudi B; Shahmohamadi E; Rasoolinejad M; Hasannezhad M; Rashidi MR; Dadras O; Moradi A; Parmoon Z; Ebrahimi H; Asadollahi-Amin A
Int J Prison Health; 2023 Feb; ():. PubMed ID: 36757302
[TBL] [Abstract][Full Text] [Related]
44. Seropositivity of hepatitis C in prison inmates of Pakistan--a cross sectional study in prisons of Sindh.
Gorar ZA; Zulfikar I
J Pak Med Assoc; 2010 Jun; 60(6):476-9. PubMed ID: 20527648
[TBL] [Abstract][Full Text] [Related]
45. Seroprevalence of Hepatitis C Virus among Prisoners in Lakan Prison, North of Iran, Is There Still a Concern?
Mohtasham-Amiri Z; Rezvani SM; Ashoori F; Behboodi M; Toosi H; Jafari-Shakib R
Arch Iran Med; 2021 Oct; 24(10):765-770. PubMed ID: 34816699
[TBL] [Abstract][Full Text] [Related]
46. Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison.
Lafferty L; Treloar C; Guthrie J; Chambers GM; Butler T
J Viral Hepat; 2017 Feb; 24(2):111-116. PubMed ID: 27778436
[TBL] [Abstract][Full Text] [Related]
47. Incident hepatitis B virus infection and immunisation uptake in Australian prison inmates.
Li H; Cameron B; Douglas D; Stapleton S; Cheguelman G; Butler T; Luciani F; Lloyd AR
Vaccine; 2020 Apr; 38(16):3255-3260. PubMed ID: 32151462
[TBL] [Abstract][Full Text] [Related]
48. High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection.
Guimarães T; Granato CF; Varella D; Ferraz ML; Castelo A; Kallás EG
Braz J Infect Dis; 2001 Jun; 5(3):111-8. PubMed ID: 11506773
[TBL] [Abstract][Full Text] [Related]
49. Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: a cohort study.
Champion JK; Taylor A; Hutchinson S; Cameron S; McMenamin J; Mitchell A; Goldberg D
Am J Epidemiol; 2004 Mar; 159(5):514-9. PubMed ID: 14977648
[TBL] [Abstract][Full Text] [Related]
50. Prisons and HCV: a review and a report on an experience in New South Wales Australia.
Batey RG; Jones T; McAllister C
Int J Prison Health; 2008; 4(3):156-63. PubMed ID: 18698530
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy.
Skipper C; Guy JM; Parkes J; Roderick P; Rosenberg WM
Gut; 2003 Oct; 52(10):1500-4. PubMed ID: 12970145
[TBL] [Abstract][Full Text] [Related]
52. Comparison of risk-based hepatitis C screening and the true seroprevalence in an urban prison system.
Kuncio DE; Newbern EC; Fernandez-Viña MH; Herdman B; Johnson CC; Viner KM
J Urban Health; 2015 Apr; 92(2):379-86. PubMed ID: 25795212
[TBL] [Abstract][Full Text] [Related]
53. Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.
He T; Li K; Roberts MS; Spaulding AC; Ayer T; Grefenstette JJ; Chhatwal J
Ann Intern Med; 2016 Jan; 164(2):84-92. PubMed ID: 26595252
[TBL] [Abstract][Full Text] [Related]
54. Transmission of Hepatitis C Virus among Prisoners, Australia, 2005-2012.
Bretaña NA; Boelen L; Bull R; Teutsch S; White PA; Lloyd AR; Luciani F;
Emerg Infect Dis; 2015 May; 21(5):765-74. PubMed ID: 25897788
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy.
Semaille C; Le Strat Y; Chiron E; Chemlal K; Valantin MA; Serre P; Caté L; Barbier C; Jauffret-Roustide M;
Euro Surveill; 2013 Jul; 18(28):. PubMed ID: 23870097
[TBL] [Abstract][Full Text] [Related]
56. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran.
Mohammad Alizadeh AH; Alavian SM; Jafari K; Yazdi N
World J Gastroenterol; 2005 Jul; 11(26):4085-9. PubMed ID: 15996035
[TBL] [Abstract][Full Text] [Related]
57. Violence and hepatitis C transmission in prison-A modified social ecological model.
Sazzad HMS; McCredie L; Treloar C; Lloyd AR; Lafferty L
PLoS One; 2020; 15(12):e0243106. PubMed ID: 33259565
[TBL] [Abstract][Full Text] [Related]
58. Prevalence and epidemiological characteristics of inmates diagnosed with infectious diseases living in a region with a high number of prisons in São Paulo state, Brazil.
do Nascimento CT; Pena DZ; Giuffrida R; Bandeira Monteiro FN; da Silva FA; Flores EF; Prestes-Carneiro LE
BMJ Open; 2020 Sep; 10(9):e037045. PubMed ID: 32895275
[TBL] [Abstract][Full Text] [Related]
59. Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary.
Tresó B; Barcsay E; Tarján A; Horváth G; Dencs A; Hettmann A; Csépai MM; Gyori Z; Rusvai E; Takács M
J Urban Health; 2012 Feb; 89(1):108-16. PubMed ID: 22143408
[TBL] [Abstract][Full Text] [Related]
60. Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting.
Lafferty L; Rance J; Treloar C
Drug Alcohol Depend; 2018 Feb; 183():96-101. PubMed ID: 29245104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
